Background: A variety of risk prediction scores have been devised to identify patients at increased risk for VTE in different patient populations and settings. Guideline recommendations for VTE risk assessment vary greatly. We performed a systematic review to identify and synthesize evidence on clinical risk prediction scores for VTE in medical and surgical hospitalized patients. [...]

Background: Venous thromboembolism (VTE) is the leading cause of preventable hospital death. National guidelinesrecommend VTE prophylaxis for all medical patients not at low risk. Several VTE risk prediction models have been developed, but no US models have been validated in a medical population. The ACCP recommends use of the Padua risk assessment model with a [...]

Background: A variety of risk prediction scores have been devised to identify patients at increased risk for VTE in different patient populations and settings. Guideline recommendations for VTE risk assessment vary greatly. We performed a systematic review to identify and synthesize evidence on clinical risk prediction scores for VTE in medical and surgical hospitalized patients. [...]

Background: Venous thromboembolism (VTE) is the leading cause of preventable hospital death. National guidelinesrecommend VTE prophylaxis for all medical patients not at low risk. Several VTE risk prediction models have been developed, but no US models have been validated in a medical population. The ACCP recommends use of the Padua risk assessment model with a [...]

Background: Clinical practice guidelines state that mobility is supposed to play an important role in determining use and duration of pharmacologic VTE prophylaxis. This study examines whether measured mobility levels relate to pharmacologic VTE prophylaxis use among hospitalized older adults. Methods: Prospective observational data from a sample of community-dwelling older adults aged ≥ 60 years, [...]

Background: Venous thromboembolism (VTE) is a serious and all too frequent hospital complication, therefore assessing each patient’s individual risk of VTE is an important part of their care.  Multiple models are available for risk assessment, however most not only include multiple data points requiring redundant entry, but can be labor intensive and time-consuming to complete on [...]

Background: Venous thromboembolism (VTE) is a significant cause of morbidity and mortality for hospitalized patients. There are approximately 900,000 new VTE events and 100,000 VTE-related deaths every year. In the United States, more deaths occur due to VTE than breast cancer, AIDS, and motor vehicle accidents combined. VTE are considered preventable events with appropriate prophylaxis; [...]

Background: Health information technology (HIT) has the potential to decrease rates of hospital-acquired conditions. The Patient Safety Learning Lab (PSLL) developed a suite of HIT tools to engage patients, families, and providers in identifying, assessing, and reducing patient safety threats. The goal of this current evaluation is to quantify the effects of this intervention on [...]

Background: Venous thromboembolism (VTE) is a leading cause of preventable in-hospital mortality and a primary focus of quality improvement/patient safety efforts. VTE prophylaxis reduces the incidence of in-hospital VTE, but nonadministration rates—primarily attributed to patient refusal—often reach 10-15%. Notably, nonadministration of VTE prophylaxis may correlate with higher incidence of hospital acquired VTE. Prior studies showed [...]

Background: Venous thromboembolism (VTE) is a prevalent and costly medical condition in hospitalized patients. Risk assessment tools like the Padua Predictive Score aim to differentiate low-risk and high-risk patients for targeted pharmaceutical prophylaxis (pPPX) administration. However, widespread adoption of risk assessment remains suboptimal. This study investigates HA VTE prophylaxis use in medicine inpatients within a [...]